• 1
    Ziegler, S. F., FOXP3 of mice and men. Annu. Rev. Immunol. 2006. 24: 209226.
  • 2
    Williams, L. M. and Rudensky, A. Y., Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 2007. 8: 277284.
  • 3
    Wan, Y. Y. and Flavell, R. A., Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007. 445: 766770.
  • 4
    Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A. and Rudensky, A. Y., Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007. 445: 771775.
  • 5
    Hill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., Mathis, D. and Benoist, C., Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007. 27: 786800.
  • 6
    Lin, W., Haribhai, D., Relland, L. M., Truong, N., Carlson, M. R., Williams, C. B. and Chatila, T. A., Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 2007. 8: 359368.
  • 7
    Allan, S. E., Alstad, A. N., Merindol, N., Crellin, N. K., Amendola, M., Bacchetta, R., Naldini, L. et al., Generation of potent and stable human CD4(+) T regulatory cells by activation-independent expression of FOXP3. Mol. Ther. 2008. 16: 194202.
  • 8
    Allan, S. E., Passerini, L., Bacchetta, R., Crellin, N., Dai, M., Orban, P. C., Ziegler, S. F. et al., The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 2005. 115: 32763284.
  • 9
    Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G. and Levings, M. K., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 2007. 19: 345354.
  • 10
    Tran, D. Q., Ramsey, H. and Shevach, E. M., Induction of FOXP3 expression in naive human CD4+ FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007. 110: 29832990.
  • 11
    Samuels, M. L., Weber, M. J., Bishop, J. M. and McMahon, M., Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell Biol. 1993. 13: 62416252.
  • 12
    Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E. and McMahon, M., Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell Biol. 1997. 17: 55985611.
  • 13
    Lopes, J. E., Torgerson, T. R., Schubert, L. A., Anover, S. D., Ocheltree, E. L., Ochs, H. D. and Ziegler, S. F., Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J. Immunol. 2006. 177: 31333142.
  • 14
    Superti-Furga, G., Bergers, G., Picard, D. and Busslinger, M., Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins. Proc. Natl. Acad. Sci. USA 1991. 88: 51145118.
  • 15
    Johansson, K. A., Dursun, U., Jordan, N., Gu, G., Beermann, F., Gradwohl, G. and Grapin-Botton, A., Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev. Cell 2007. 12: 457465.
  • 16
    Chen, C., Rowell, E. A., Thomas, R. M., Hancock, W. W. and Wells, A. D., Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 2006. 281: 3682836834.
  • 17
    Levings, M. K., Sangregorio, R., Sartirana, C., Moschin, A. L., Battaglia, M., Orban, P. C. and Roncarolo, M. G., Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 2002. 196: 13351346.
  • 18
    Singh, B., Read, S., Asseman, C., Malmstrom, V., Mottet, C., Stephens, L. A., Stepankova, R. et al., Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 2001. 182: 190200.
  • 19
    Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R. et al., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007. 450: 566569.
  • 20
    Niedbala, W., Wei, X. Q., Cai, B., Hueber, A. J., Leung, B. P., McInnes, I. B. and Liew, F. Y., IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 2007. 37: 30213029.
  • 21
    Batten, M. and Ghilardi, N., The biology and therapeutic potential of interleukin 27. J. Mol. Med. 2007. 85: 661672.
  • 22
    Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L. et al., FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006. 126: 375387.
  • 23
    Li, B., Samanta, A., Song, X., Furuuchi, K., Iacono, K. T., Kennedy, S., Katsumata, M. et al., FOXP3 ensembles in T-cell regulation. Immunol. Rev. 2006. 212: 99113.
  • 24
    Torgerson, T. R. and Ochs, H. D., Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J. Allergy Clin. Immunol. 2007. 120: 744750.
  • 25
    Venken, K., Hellings, N., Thewissen, M., Somers, V., Hensen, K., Rummens, J. L., Medaer, R. et al., Compromised CD4(+) CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2007 123: 7989.
  • 26
    Tao, R., de Zoeten, E. F., Ozkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B. et al., Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 2007. 13: 12991307.